ProShares UltraShort NASDAQ Biotechnology
10 hedge funds and large institutions have $1.88M invested in ProShares UltraShort NASDAQ Biotechnology in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.
Holders
10
Holders Change
-3
Holders Change %
-23.08%
% of All Funds
0.25%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
3
Reduced
3
Closed
4
Calls
$689K
Puts
$241K
Net Calls
+$448K
Net Calls Change
-$4.76M
Top Buyers
1 |
VF
1
Virtu Financial
New York
|
$643K |
2 |
2
Citadel Advisors
Miami,
Florida
|
$252K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$66K |
4 |
AG
4
Advisor Group
Phoenix,
Arizona
|
$10K |